首页 > 市场调查报告书 > 製药

生技设备生物工艺

市场调查报告书

商品编码

1375201

北美生物製程技术市场预测至 2028 年 - 按类型、模式和最终用户进行的区域分析

North America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: 2023年09月14日 | 出版商:

The Insight Partners | 英文 129 Pages | 订单完成后即时交付

价格

简介目录图表

北美生物製程技术市场预计将从2023年的158.6906亿美元成长到2028年的336.9606亿美元。预计2023年至2028年复合年增长率为16.3%。

慢性病盛行率不断上升推动北美生物製程技术市场

空前的人口老化速度和长期缺乏身体活动正在加剧肥胖和糖尿病等生活方式障碍的盛行率。基因可导致心血管疾病 (CVD)、糖尿病、肥胖、阿兹海默症和忧郁症等疾病。据国家老化委员会称，80% 的成年人（65 岁及以上）一生中至少患有一种慢性病，而 68% 的人患有两种或两种以上。根据美国疾病管制与预防中心(CDC) 的数据，2020 年，美国每10 人中就有近6 人患有至少一种严重疾病，每10 人中就有4 人患有两种或两种以上慢性病。心血管疾病，如心绞痛忙碌的生活方式引起的动脉粥状硬化和急性心肌梗塞是该地区死亡的重要原因。糖尿病是一种危及生命的慢性疾病，无法进行功能性治癒。所有类型的糖尿病都会在不同的身体部位引起各种併发症，增加整体死亡风险。心臟病、肾衰竭、中风、截肢、神经损伤和视力丧失是与糖尿病相关的主要併发症。根据国际糖尿病联盟（IDF）预测，北美糖尿病病例预计将从2017年的4,600万增加到2045年的6,200万人。资料进一步显示，2017年有4.25亿人患有糖尿病，这一数字很可能达到2045年，全球人口将达6.29 亿。在预测期内，该疾病的盛行率可能会增加约 35%。患者、专家、初级保健临床医生和其他医疗保健专业人员认识到生物相似药是有效且安全的药物，这正在推动其需求。生物相似药已被证明可以改善数百万患者的生活品质。它们是治疗许多疾病的有效且经济有效的选择，包括慢性皮肤病（如牛皮癣、异位性皮肤炎）、肠道疾病（如克罗恩病、肠躁症和结肠炎）、糖尿病、自身免疫性疾病、癌症、肾臟病条件和关节炎。生物相似药开发商正在采用先进的生物加工技术来降低製造成本，这是决定最终消费者价格的重要因素。几乎所有生物相似药开发商都在使用现代的、通常是尖端的生物加工技术。这表明大多数生物相似药是使用一次性（使用后处置）生物加工系统开发的。随着慢性病的日益流行，对治疗危及生命的疾病的生物相似药的需求不断增加，从而推动了对生物加工技术的需求。

北美生物製程技术市场概况

根据美国食品药物管理局 (FDA) 的报告，美国有超过 3,000 万人患有约 7,000 种罕见疾病，这些疾病危及生命，但治疗选择却很少。由于缺乏对罕见疾病历史的了解以及临床试验的困难，治疗罕见疾病的药物、生物和设备开发具有挑战性。因此，基因和细胞疗法（CGT）以及特种药物等生物製程技术的发展代表了罕见疾病治疗的根本转变。例如，与治疗罕见疾病的配方药物相比，CGT 具有显着的健康益处。在美国，超过 900 项针对基因治疗产品的研究性新药 (IND) 申请正在进行中。此外，FDA 每年批准 10-20 种基因疗法。同样，2022 年 8 月，FDA 批准了 Bluebird Bio 的「Zynteglo (betibeglogene autotemcel)」。这是美国批准的最昂贵的单次申请药物，用于治疗一种罕见的神经系统疾病—脑性肾上腺脑白质营养不良（CALD）。

北美生物製程技术市场收入及 2028 年预测（百万美元）

北美生物製程技术市场细分

北美生物製程技术市场按类型、模式、最终用户和国家进行细分。

根据类型，北美生物製程技术市场分为细胞培养基生物製程、色谱生物製程以及消耗品和配件等。 2023年，细胞培养基生物製程领域在北美生物製程技术市场中占据最大份额。

根据模式，北美生物加工技术市场分为一次性使用和多次使用。 2023 年，一次性细分市场在北美生物製程技术市场中占据更大份额。

根据最终用途，北美生物製程技术市场分为学术和医疗机构、生物製药公司、研究实验室等。 2023年，生物製药公司细分市场在北美生物製程技术市场中占据最大份额。

根据国家/地区，北美生物工艺技术市场分为美国、加拿大和墨西哥。 2023年，美国市场在北美生物製程技术市场中占据最大份额。

康宁公司；丹纳赫公司；艾本德公司；龙沙集团股份公司；默克公司；雷普利根公司；赛多利斯公司；斯塔姆生物技术公司；和 Thermo Fisher Scientific Inc 是北美生物製程技术市场上的一些领先公司。

The unprecedented rate of aging population and extended periods of physical inactivity are boosting the prevalence lifestyle disorders, such as obesity and diabetes. Genes can cause conditions such as cardiovascular disease (CVDs), diabetes, obesity, Alzheimer's disease, and depression. According to the National Council on Aging, Inc., 80% of adults (aged 65 and more) are reported to suffer from at least one chronic condition in their lifetime, while 68% have two or more. According to the Centers for Disease Control and Prevention (CDC), nearly 6 of 10 people in the US suffered from at least one serious disease, and 4 of 10 people have had two or more chronic conditions in 2020. CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction, caused due to hectic lifestyles are significant causes of mortality across the region. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can cause various complications in different body parts, thereby increasing the overall risk of death. Heart attack, kidney failure, stroke, leg amputation, nerve damage, and vision loss are among the major complications associated with diabetes. According to the International Diabetes Federation (IDF), diabetic cases in North America are expected to reach 62 million by 2045 from 46 million in 2017. The data further reported that 425 million people suffered from diabetes in 2017, and the count is likely to reach 629 million by 2045 worldwide. The disease prevalence is likely to increase by about 35% during the forecast period. Recognition of biosimilars as efficacious and safe agents by patients, specialists, primary care clinicians, and other healthcare professionals is propelling its demand. Biosimilars have proven to improve the quality of life for millions of patients. They are effective and cost-effective options in treating many diseases, including chronic skin conditions (such as psoriasis, Atopic Dermatitis), bowel diseases (such as Crohn's disease, irritable bowel syndrome, and colitis), diabetes, autoimmune disease, cancer, kidney conditions, and arthritis. Biosimilar developers are adopting advanced bioprocessing technologies to achieve lower manufacturing costs, an important factor determining final consumer prices. Nearly all biosimilar developers are using modern, often cutting-edge bioprocessing techniques. This indicates that a majority of biosimilars are being developed using single use (disposed of after-use) bioprocessing systems. With the growing prevalence of chronic diseases, the demand for biosimilars to treat life-threatening illnesses is spurring, thereby propelling the demand for bioprocessing technologies.

North America Bioprocess Technology Market Overview

According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).

North America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

North America Bioprocess Technology Market Segmentation

The North America bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the North America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the cell culture media bioprocess segment registered a largest share in the North America bioprocess technology market.

Based on modality, the North America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the North America bioprocess technology market.

Based on end-use, the North America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered a largest share in the North America bioprocess technology market.

Based on country, the North America bioprocess technology market is segmented into the US, Canada, and Mexico. In 2023, the US segment registered a largest share in the North America bioprocess technology market.

Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America bioprocess technology market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioprocess technology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Bioprocess Technology Market - by Type
- 1.3.2 North America Bioprocess Technology Market - by Modality
- 1.3.3 North America Bioprocess Technology Market - by End User
- 1.3.1 North America Bioprocess Technology Market - by Country

2. North America Bioprocess Technology Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Bioprocess Technology Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion

5. North America Bioprocess Technology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
- 5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
- 5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
- 5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis

6. Bioprocess Technology Market - North America Analysis

6.1 North America Bioprocess Technology Market Revenue Forecast and Analysis

7. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

7.1 Overview
7.2 North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
- 7.3.1 Overview
- 7.3.2 Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
- 7.4.1 Overview
- 7.4.2 Chromatography Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
- 7.5.1 Overview
- 7.5.2 Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

8.1 Overview
8.2 North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
- 8.3.1 Overview
- 8.3.2 Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
- 8.4.1 Overview
- 8.4.2 Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
- 9.3.1 Overview
- 9.3.2 Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
- 9.4.1 Overview
- 9.4.2 Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
- 9.5.1 Overview
- 9.5.2 Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

10.1 North America: Bioprocess Technology Market
- 10.1.1 Overview
- 10.1.2 North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.2.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. North America Bioprocess Technology Market - Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sartorius AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Corning Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 STAMM Biotech
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lonza Group AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Eppendorf SE
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Repligen Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Danaher Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 12. Recent Inorganic Growth Strategies in the North America bioprocess technology market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Bioprocess Technology Market Segmentation
Figure 2. North America Bioprocess Technology Market, by Country
Figure 3. North America Bioprocess Technology Market Overview
Figure 4. Cell Culture Media Bioprocess Segment Held Largest Share of Type Segment in North America Bioprocess Technology Market
Figure 5. Canada Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. North America Bioprocess Technology Market Impact and Analysis
Figure 9. North America Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)